Background The decrease in incidence of cervical dysplasia and carcinoma has not been as
dramatic as expected with the development of improved research tools and test methods …

Objective: The aim of this study was to compare the diagnostic accuracy of the Pap test,
liquid-based cytology (LBC), and human papillomavirus (HPV) testing used as screening …

Background Previous studies have indicated that negative Papanicolaou (Pap) tests can
precede high‐grade cervical lesions (HGCL) on biopsy. This study aims to determine the …

BACKGROUND Because of cervical cancer screening recommendations and forthcoming
first‐line human papillomavirus (HPV) screening, many Papanicolaou (Pap) tests will be …

Context.—High-risk human papillomaviruses (HPVs) are causal factors of cervical
carcinomas. Objective.—To evaluate the sensitivity and efficiency of HPV DNA testing in …

Human papillomavirus (HPV) infection is a necessary cause of cervical cancer; HPV testing
capitalizes on this fact to maximize the clinical benefits of cervical screening and abnormal …

Background: Results of cervical cytology screening showing atypical squamous cells of
undetermined significance (ASCUS) or low-grade squamous intraepithelial lesions (LSIL) …

Objective The current system of Pap smear screening and management of abnormal
cytology has resulted in a marked reduction in invasive cervical cancer. Many women …

Context Cervical cancer mortality has declined by 74% in the United States since the
implementation of the Papanicolaou (Pap) test. Nevertheless, more than 12 000 US women …

To assess the performance of human papillomavirus (HPV) testing and colposcopy in
detection of cervical pathology. A series of 389 women referred for colposcopy due to an …